HDO Health Founder and CEO, Bryan Stewart, shared the HDO Health story with a diverse audience of investor, entrepreneurs, and innovators at the Bullpen Pitch Fest in Minneapolis, MN. It was a great opportunity to network, engage, and learn.

HDO Health was selected to participate in the upcoming Encountering Innovation virtual pitch event July 22 – 26. This is another great opportunity for us to connect and share about the HDO Health Journiquet with other innovators, other manufacturing and technology companies (from Federal Agency Prime Contractors to Small Businesses), and government Technology Scounts and to collaborate with others for commercialization and cContracting purposes via private tech transfer pitches and matchmaking sessions.

HDO Health was Featured on The Ohio State University College of Engineering Website. A recent article on The Ohio State University College of Engineering website features HDO Health‘s life-saving medical device, the Journiquet™, co-invented by Tanya Nocera, a biomedical engineering associate professor of practice, along with J. Allen McElroy, a trauma surgeon and Ohio State alumnus, Nadi Graham, an Ohio State Highway Patrol officer and member of its special response team, and Bryan Stewart, an Ohio State alumnus who is now the CEO of HDO Health.  The article highlights the years-long journey of Nocera, McElroy, Graham, and later Stewart in developing and bringing the Journiquet™ to market, which started with a senior

Andrew Cothrel brings 30+ years of healthcare and medical device experience to support HDO Health in achieving its mission to bring life-saving medical devices to the world. HDO Health announced today the appointment of Mr. Andrew Cothrel to their Board of Directors. “We are thrilled to add a leader of Andrew’s caliber and experience to our Board. His alignment with our core values and deep experience and network in the segment will pay huge dividends for us as we enter the market and accelerate our growth,” said Bryan Stewart Founder and CEO of HDO Health. Andrew Cothrel is President of Rushlight Ventures, focused on monetizing the IP of small to

HDO Health is excited to announce participation in the 2022 Spring Ohio State Technology Showcase hosted by the Keenan Center for Entrepreneurship on Thursday May 19, 2022 from 5 – 7 pm EST at the Idea Foundry, 421 W. State Street, Columbus, OH 43215. The event is to highlight the brilliant researchers who are discovering and creating exciting commercially viable technologies at The Ohio State University. HDO Health will be sharing about our technology, our innovative junctional tourniquet (The Journiquet) designed to help save the lives of individuals who have suffered a traumatic junctional wound. This technology is a past recipient of funding from the Ohio State Accelerator Awards, a

HDO Health was recently featured on the Rev1 Ventures blog. Click here to view on the Rev1 Ventures website. HDO Health, a medical device startup based in Columbus, OH, is all about saving lives. HDO Health’s Junctional Tourniquet (‘the Journiquet”), a class II medical device, innovates on current junctional tourniquet options. Its innovative design creates a tourniquet that stops bleeding faster. That’s because the Journiquet is easier for emergency responders and medical professionals to use and is more compact and portable at a more affordable price than existing junctional tourniquets. HDO Health is developing and commercializing the Journiquet in partnership with The Ohio State University and the OSU Innovation Foundation

HDO Health is excited to announce its selection as a participant company for the 2022 Cohort of The Ohio State University Keenan Center for Entrepreneurship Wheeler and Wolstein Internship Program The Wheeler & Wolstein Internship Program provides scholarship funding to undergraduate and graduate students in internships with startup companies and small businesses. The program matches students with organizations offering a project-based internship during the summer term (May-August). Selected students receive a $7,000 scholarship to cover a living stipend during the summer term. There is no financial cost to participating organizations. HDO Health is proud to have Olivia (Vick) Hillrich join our team for the summer. Three of the HDO Health

HDO Health was recently awarded a Technology Validation and Startup Fund (TVSF) Phase 2 Grant from Ohio Third Frontier. Ohio Third Frontier is an internationally recognized, technology-based economic development initiative that is successfully changing the trajectory of Ohio’s economy. Third Frontier works with innovative startup companies across the state, making Ohio the destination for technology entrepreneurs. This robust network of resources helps take advanced ideas and turn them into new technology businesses. HDO Health will be utilizing the non-dilutive grant funds to further develop and finalize the design for their innovative junctional tourniquet (The Journiquet™) and prepare for a Class II U.S. Federal Drug Administration (FDA) 510(k) filing and clearance

HDO Health is proud to announce that they have been selected for an initial engagement as part of the Rev1 Ventures startup studio. Rev1 Ventures is a unique investor startup studio that helps startups scale and corporates innovate. This engagement includes the pairing of the HDO Health founding team with a team of start-up advisors. In addition, it provides free access to significant learning resources, service providers, and a network of other entrepreneurs leading high-growth companies. This strategic partnership connects HDO Health to the talent, customers, space, and funding we need — when we need it. Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

The HDO Health team recently completed a TVSF Phase 1 funding and development cycle. The goal of the TVSF Phase 1 was to advance the design and fabricate functional prototypes in preparation for future demonstrations and operational testing of the HDO Health junctional tourniquet (the Journiquet). The objectives were to take the design through Technology Readiness Level (TRL) 6 with a system prototype demonstrated in a laboratory environment on a medical manikin with experienced users. The project results included capturing and documenting user requirements for a minimally viable product (MVP), fabrication of mock-ups of the preliminary design to support usability sessions conducted with military and EMT personnel to gather user